Neuralink competitor Elon Musk has begun recruiting patients for clinical trials of a neuroimplant. More than 100 organizations have expressed their willingness to participate in the trial, Synchron said. The company’s implant will allow paralyzed people to control the functions of electronic devices with the power of thought.
Join
The startup Synchron announced the start of recruiting patients for clinical trials of its neuroimplant. The list to test the chip will include several dozen people, said Synchron CEO Thomas Oxley.
Synchron received permission to research its chips in July 2021. The devices were implanted in several patients and no serious side effects were found from their implementation, the company said.
Synchron is a direct competitor to Elon Musk’s Neuralink. In March, the company showed the first results of a chip implanted in the human brain.
Author:
Kirill Bilyk
Source: RB
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
